Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing
Neurobiology of Disease · 2024
DOI: 10.1016/j.nbd.2023.106367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2024. Verfasst von Kizito-Tshitoko Tshilenge und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Buck Institute for Research on Aging, Novato, California 94945, USA. Hauptthemen laut MEDLINE: Parkinsonian Disorders, Neurodegenerative Diseases, Dystonic Disorders, Dystonia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
X-linked dystonia-parkinsonism (XDP) is a rare neurodegenerative disease endemic to the Philippines. The genetic cause for XDP is an insertion of a SINE-VNTR-Alu (SVA)-type retrotransposon within intron 32 of TATA-binding protein associated factor 1 (TAF1) that causes an alteration of TAF1 splicing, partial intron retention, and decreased transcription. Although TAF1 is expressed in all organs, medium spiny neurons (MSNs) within the striatum are one of the cell types most affected in XDP. To define how mutations in the TAF1 gene lead to MSN vulnerability, we carried out a proteomic analysis of human XDP patient-derived neural stem cells (NSCs) and MSNs derived from induced pluripotent stem cells. NSCs and MSNs were grown in parallel and subjected to quantitative proteomic analysis in data-independent acquisition mode on the Orbitrap Eclipse Tribrid mass spectrometer. Subsequent functional enrichment analysis demonstrated that neurodegenerative disease-related pathways, such as Huntington's disease, spinocerebellar ataxia, cellular senescence, mitochondrial function and RNA binding metabolism, were highly represented. We used weighted coexpression network analysis (WGCNA) of the NSC and MSN proteomic data set to uncover disease-driving network modules. Three of the modules significantly correlated with XDP genotype when compared to the non-affected control and were enriched for DNA helicase and nuclear chromatin assembly, mitochondrial disassembly, RNA location and mRNA processing. Consistent with aberrant mRNA processing, we found splicing and intron retention of TAF1 intron 32 in XDP MSN. We also identified TAF1 as one of the top enriched transcription factors, along with YY1, ATF2, USF1 and MYC. Notably, YY1 has been implicated in genetic forms of dystonia. Overall, our proteomic data set constitutes a valuable resource to understand mechanisms relevant to TAF1 dysregulation and to identify new therapeutic targets for XDP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Buck Institute for Research on Aging, Novato, California 94945, USA.
- The Buck Institute for Research on Aging, Novato, California 94945, USA; University of Southern California, Leonard Davis School of Gerontology, 3715 McClintock Ave, Los Angeles, CA 90893, USA.
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Neurology, The Collaborative Center for X-linked Dystonia-Parkinsonism, Massachusetts General Hospital,…
- The Buck Institute for Research on Aging, Novato, California 94945, USA; University of Southern California, Leonard Davis School of Gerontology, 3715 McClintock Ave, Los Angeles, CA 90893, USA. Electronic address: bschi…
- The Buck Institute for Research on Aging, Novato, California 94945, USA; University of Southern California, Leonard Davis School of Gerontology, 3715 McClintock Ave, Los Angeles, CA 90893, USA. Electronic address: lelle…
Förderung
- NINDS NIH HHS
- NIH HHS
Zitieren
APA
Tshilenge, K. T., Bons, J., Aguirre, C. G., Geronimo-Olvera, C., Shah, S., Rose, J., Gerencser, A. A., Mak, S. K., Ehrlich, M. E., Bragg, D. C., Schilling, B., & Ellerby, L. M. (2024). Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2023.106367
Vancouver
Tshilenge KT, Bons J, Aguirre CG, Geronimo-Olvera C, Shah S, Rose J, et al. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing. Neurobiology of Disease. 2024. doi:10.1016/j.nbd.2023.106367
BibTeX
@article{Tshilenge2024,
author = {Tshilenge, Kizito-Tshitoko and Bons, Joanna and Aguirre, Carlos Galicia and Geronimo-Olvera, Cristian and Shah, Samah and Rose, Jacob and Gerencser, Akos A and Mak, Sally K and Ehrlich, Michelle E and Bragg, D Cristopher and Schilling, Birgit and Ellerby, Lisa M},
title = {Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing},
journal = {Neurobiology of Disease},
year = {2024},
doi = {10.1016/j.nbd.2023.106367}
}
EUVIMED